Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Intellia Therapeutics (NTLA) has provided an update.
Intellia Therapeutics has appointed Michael P. Dube as the new principal accounting officer. With a solid background in finance and accounting, Dube brings experience from his previous role as Global Corporate Controller at Abiomed, Inc. and a decade at Deloitte & Touche LLP. His expertise as a certified public accountant reinforces Intellia’s financial leadership team as they continue to innovate in the biotechnology sector.
For a thorough assessment of NTLA stock, go to TipRanks’ Stock Analysis page.